Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             104 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adjuvant High-Flow Normobaric Oxygen After Mechanical Thrombectomy for Anterior Circulation Stroke: a Randomized Clinical Trial Cheng, Zhe

18 2 p. 1188-1197
artikel
2 Adjuvant High-Flow Normobaric Oxygen After Mechanical Thrombectomy for Anterior Circulation Stroke: a Randomized Clinical Trial Cheng, Zhe

18 2 p. 1188-1197
artikel
3 Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study Li, Xi Rong

18 2 p. 1316-1324
artikel
4 Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study Li, Xi Rong

18 2 p. 1316-1324
artikel
5 A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats Rojas, Asheebo

18 2 p. 1207-1225
artikel
6 A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats Rojas, Asheebo

18 2 p. 1207-1225
artikel
7 Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation Bamia, Aline

18 2 p. 1137-1150
artikel
8 Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation Bamia, Aline

18 2 p. 1137-1150
artikel
9 Blocking the Spinal Fbxo3/CARM1/K+ Channel Epigenetic Silencing Pathway as a Strategy for Neuropathic Pain Relief Hsieh, Ming-Chun

18 2 p. 1295-1315
artikel
10 Blocking the Spinal Fbxo3/CARM1/K+ Channel Epigenetic Silencing Pathway as a Strategy for Neuropathic Pain Relief Hsieh, Ming-Chun

18 2 p. 1295-1315
artikel
11 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control van der Merwe, Yolandi

18 2 p. 1339-1359
artikel
12 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control van der Merwe, Yolandi

18 2 p. 1339-1359
artikel
13 Correction to: Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis Fani Maleki, Adham

18 2 p. 1426
artikel
14 Correction to: Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis Fani Maleki, Adham

18 2 p. 1426
artikel
15 Correction to: The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome Jonak, Carrie R.

18 2 p. 1427
artikel
16 Correction to: The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome Jonak, Carrie R.

18 2 p. 1427
artikel
17 Decreased Level of Exosomal miR-5121 Released from Microglia Suppresses Neurite Outgrowth and Synapse Recovery of Neurons Following Traumatic Brain Injury Zhao, Chengcheng

18 2 p. 1273-1294
artikel
18 Decreased Level of Exosomal miR-5121 Released from Microglia Suppresses Neurite Outgrowth and Synapse Recovery of Neurons Following Traumatic Brain Injury Zhao, Chengcheng

18 2 p. 1273-1294
artikel
19 Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology Rao, Shalini S.

18 2 p. 1081-1094
artikel
20 Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology Rao, Shalini S.

18 2 p. 1081-1094
artikel
21 Effect of Capsaicinoids on Neurophysiological, Biochemical, and Mechanical Parameters of Swallowing Function Suntrup-Krueger, Sonja

18 2 p. 1360-1370
artikel
22 Effect of Capsaicinoids on Neurophysiological, Biochemical, and Mechanical Parameters of Swallowing Function Suntrup-Krueger, Sonja

18 2 p. 1360-1370
artikel
23 Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study Preziosa, Paolo

18 2 p. 878-888
artikel
24 Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study Preziosa, Paolo

18 2 p. 878-888
artikel
25 Ethical Considerations in Communicating Alzheimer’s Disease Neuroimaging Biomarker Test Results to Symptomatic Individuals Wilkenfeld, Daniel A.

18 2 p. 673-685
artikel
26 Ethical Considerations in Communicating Alzheimer's Disease Neuroimaging Biomarker Test Results to Symptomatic Individuals Wilkenfeld, Daniel A.

18 2 p. 673-685
artikel
27 Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study Zanghì, Aurora

18 2 p. 1166-1174
artikel
28 Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study Zanghì, Aurora

18 2 p. 1166-1174
artikel
29 Ferulic Acid Ameliorates Alzheimer’s Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice Wang, Ni-Ya

18 2 p. 1064-1080
artikel
30 Ferulic Acid Ameliorates Alzheimer's Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice Wang, Ni-Ya

18 2 p. 1064-1080
artikel
31 Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling Ho, Kuo-Hao

18 2 p. 1371-1392
artikel
32 Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling Ho, Kuo-Hao

18 2 p. 1371-1392
artikel
33 Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism Brooks, David J.

18 2 p. 753-771
artikel
34 Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism Brooks, David J.

18 2 p. 753-771
artikel
35 Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register D’Amico, Emanuele

18 2 p. 905-919
artikel
36 Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register D'Amico, Emanuele

18 2 p. 905-919
artikel
37 LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo Van der Perren, Anke

18 2 p. 949-961
artikel
38 LRRK2 Ablation Attenuates Αlpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo Van der Perren, Anke

18 2 p. 949-961
artikel
39 Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis Ruetsch-Chelli, Caroline

18 2 p. 938-948
artikel
40 Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis Ruetsch-Chelli, Caroline

18 2 p. 938-948
artikel
41 Neuroimaging Advances in Neurologic and Neurodegenerative Diseases Risacher, Shannon L.

18 2 p. 659-660
artikel
42 Neuroimaging Advances in Neurologic and Neurodegenerative Diseases Risacher, Shannon L.

18 2 p. 659-660
artikel
43 Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic Alosco, Michael L.

18 2 p. 772-791
artikel
44 Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic Alosco, Michael L.

18 2 p. 772-791
artikel
45 Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology Peet, Bradley T.

18 2 p. 728-752
artikel
46 Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology Peet, Bradley T.

18 2 p. 728-752
artikel
47 Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington’s Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31 Simmons, Danielle A.

18 2 p. 1039-1063
artikel
48 Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31 Simmons, Danielle A.

18 2 p. 1039-1063
artikel
49 Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy Bu, Lu-Lu

18 2 p. 962-978
artikel
50 Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy Bu, Lu-Lu

18 2 p. 962-978
artikel
51 Noninvasive Neuroprosthesis Promotes Cardiovascular Recovery After Spinal Cord Injury Sachdeva, Rahul

18 2 p. 1244-1256
artikel
52 Noninvasive Neuroprosthesis Promotes Cardiovascular Recovery After Spinal Cord Injury Sachdeva, Rahul

18 2 p. 1244-1256
artikel
53 Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia Rivas-Santisteban, Rafael

18 2 p. 998-1016
artikel
54 Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia Rivas-Santisteban, Rafael

18 2 p. 998-1016
artikel
55 Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model Daruich, Alejandra

18 2 p. 1325-1338
artikel
56 Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model Daruich, Alejandra

18 2 p. 1325-1338
artikel
57 Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical Trial Xu, Yun

18 2 p. 868-877
artikel
58 Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical Trial Xu, Yun

18 2 p. 868-877
artikel
59 Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation Tavassoly, Omid

18 2 p. 979-997
artikel
60 Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation Tavassoly, Omid

18 2 p. 979-997
artikel
61 Pipeline Embolization Device for Intracranial Aneurysms in a Large Chinese Cohort: Complication Risk Factor Analysis Kang, Huibin

18 2 p. 1198-1206
artikel
62 Pipeline Embolization Device for Intracranial Aneurysms in a Large Chinese Cohort: Complication Risk Factor Analysis Kang, Huibin

18 2 p. 1198-1206
artikel
63 Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer’s Disease Buckley, Rachel F.

18 2 p. 709-727
artikel
64 Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease Buckley, Rachel F.

18 2 p. 709-727
artikel
65 Recent Advances in Neuroimaging of Epilepsy Goodman, Adam M.

18 2 p. 811-826
artikel
66 Recent Advances in Neuroimaging of Epilepsy Goodman, Adam M.

18 2 p. 811-826
artikel
67 Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits Gooden, Matthew J.

18 2 p. 859-865
artikel
68 Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits Gooden, Matthew J.

18 2 p. 859-865
artikel
69 Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study Rudnicki, Stacy A.

18 2 p. 1127-1136
artikel
70 Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study Rudnicki, Stacy A.

18 2 p. 1127-1136
artikel
71 Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions Brandt, Stephen J.

18 2 p. 827-844
artikel
72 Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions Brandt, Stephen J.

18 2 p. 827-844
artikel
73 Reversing Accumulation of Polyglucosan Bodies by Virally Delivered CRISPR/Cas9 Genome Editing Riva, Antonella

18 2 p. 866-867
artikel
74 Reversing Accumulation of Polyglucosan Bodies by Virally Delivered CRISPR/Cas9 Genome Editing Riva, Antonella

18 2 p. 866-867
artikel
75 Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes Kútna, Viera

18 2 p. 845-858
artikel
76 Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes Kútna, Viera

18 2 p. 845-858
artikel
77 Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis Calvo-Barreiro, Laura

18 2 p. 920-937
artikel
78 Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis Calvo-Barreiro, Laura

18 2 p. 920-937
artikel
79 Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis Fani Maleki, Adham

18 2 p. 889-904
artikel
80 Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis Fani Maleki, Adham

18 2 p. 889-904
artikel
81 Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury Jin, Benita

18 2 p. 1226-1243
artikel
82 Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury Jin, Benita

18 2 p. 1226-1243
artikel
83 Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30 Fardghassemi, Yasmin

18 2 p. 1151-1165
artikel
84 Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30 Fardghassemi, Yasmin

18 2 p. 1151-1165
artikel
85 Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis Mòdol-Caballero, Guillem

18 2 p. 1113-1126
artikel
86 Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis Mòdol-Caballero, Guillem

18 2 p. 1113-1126
artikel
87 Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction McDonald, Brenna C.

18 2 p. 792-810
artikel
88 Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction McDonald, Brenna C.

18 2 p. 792-810
artikel
89 Targeting Gys1 with AAV‐SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models Gumusgoz, Emrah

18 2 p. 1414-1425
artikel
90 Targeting Gys1 with AAV‐SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models Gumusgoz, Emrah

18 2 p. 1414-1425
artikel
91 Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion Thammisetty, Sai Sampath

18 2 p. 1095-1112
artikel
92 Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion Thammisetty, Sai Sampath

18 2 p. 1095-1112
artikel
93 The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome Jonak, Carrie R.

18 2 p. 1175-1187
artikel
94 The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome Jonak, Carrie R.

18 2 p. 1175-1187
artikel
95 The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models Naia, Luana

18 2 p. 1017-1038
artikel
96 The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models Naia, Luana

18 2 p. 1017-1038
artikel
97 The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders Schwarz, Adam J.

18 2 p. 686-708
artikel
98 The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders Schwarz, Adam J.

18 2 p. 686-708
artikel
99 Transplantation of Human Neural Precursor Cells Reverses Syrinx Growth in a Rat Model of Post-Traumatic Syringomyelia Xu, Ning

18 2 p. 1257-1272
artikel
100 Transplantation of Human Neural Precursor Cells Reverses Syrinx Growth in a Rat Model of Post-Traumatic Syringomyelia Xu, Ning

18 2 p. 1257-1272
artikel
101 Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases Schwarz, Christopher G.

18 2 p. 661-672
artikel
102 Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases Schwarz, Christopher G.

18 2 p. 661-672
artikel
103 What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review Dal-Pizzol, Felipe

18 2 p. 1393-1413
artikel
104 What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review Dal-Pizzol, Felipe

18 2 p. 1393-1413
artikel
                             104 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland